Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,165.08
(
0.80%
)
US TECH 100
26,538.40
(
1.85%
)
Dow Jones
49,247.66
(
-0.13%
)
Brent Oil
101.64
(
0.10%
)
Bitcoin
78,466.19
(
-0.24%
)
News Focus
News Focus
Post# of 257443
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 843
Posts 122886
Boards Moderated 9
Alias Born 09/05/2002

DewDiligence

Member Level

Re: DewDiligence post# 207640

Friday, 01/06/2017 10:04:56 AM

Friday, January 06, 2017 10:04:56 AM

Post# of 257443
AMGN/SNY/REGN—Deep insight from RBC analyst:

http://www.wsj.com/articles/judge-rules-against-sanofi-and-regeneron-in-patent-case-1483664141

RBC Capital Markets estimated peak annual sales for Repatha could as much as double to $4 billion globally without competition from its rival.

LOL

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today